Stone Ridge Asset Management’s Quest Diagnostics DGX Stock Holding History

Stone Ridge Asset Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-13,878	Closed	-$1.48M	–	792
2019 Q4	$1.48M	Hold	13,878	–	–	0.09%	284
2019 Q3	$1.49M	Hold	13,878	–	–	0.09%	274
2019 Q2	$1.41M	Sell	13,878 -3,200	-19%	-$308K	0.08%	291
2019 Q1	$1.54M	Sell	17,078 -4,915	-22%	-$426K	0.09%	281
2018 Q4	$1.83M	Buy	21,993 +8,151	+59%	+$764K	0.11%	193
2018 Q3	$1.49M	Buy	13,842 +2,576	+23%	+$283K	0.08%	290
2018 Q2	$1.24M	Buy	11,266 +1,475	+15%	+$154K	0.07%	334
2018 Q1	$982K	Hold	9,791	–	–	0.06%	398
2017 Q4	$964K	Buy	+9,791	New	+$928K	0.06%	407

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Stone Ridge Asset Management's DGX Position: Q1 2020 in Review

Stone Ridge Asset Management sold out of Quest Diagnostics (DGX) in Q1 2020, closing a stake of 13,878 shares — an estimated $1.48M sold.

Stone Ridge Asset Management first reported a position in DGX in Q4 2017 and held it in 9 quarters. The position peaked at $1.83M in Q4 2018. 714 funds tracked by Wall St. Rank hold DGX as of Q1 2020.

Stone Ridge Asset Management reported no remaining Quest Diagnostics position as of Q1 2020 after selling out during the quarter.
Stone Ridge Asset Management sold 13,878 Quest Diagnostics shares in Q1 2020, an estimated $1.48M.
Stone Ridge Asset Management first reported a position in Quest Diagnostics in Q4 2017 and held it in 9 quarters.
Stone Ridge Asset Management's Quest Diagnostics position peaked at $1.83M in Q4 2018.
714 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.

Based on Stone Ridge Asset Management's 13F filing for Q1 2020, filed 5 May 2020.